Inside AI in Life Science

Welcome to our third episode! Join us as we engage in a thought-provoking conversation with Dr. Sarah Barnett, a CAM Assay expert from the University of Liverpool. Our focus today is on the subject of "Ethical standards and AI image analysis in CAM models".In this interview, we delve into Dr. Sarah Barnett’s remarkable journey. Initially a postdoc in Professor Judy Coulson's lab, she spearheaded the development of the CAM model to address mesothelioma, a lung lining cancer caused by asbestos. Currently serving as the Egg Facility Manager at the university, she brings a wealth of experience and insights to our discussion.Key Highlights:Discovering Dr Barnett’s current research endeavors.Insight into CAM Research and CAM Assays: Exploring their significance.Dr Barnett’s perspective on the implementation of the 3R principle in Animal Research.Exploring AI Image Analysis techniques and their role in CAM Research.Dr Barnett’s viewpoint on the role of Women in Science.Further links to our guest's profiles:https://www.liverpool.ac.uk/ Sarah Barnett’s ResearchGate profileEgg Facilty at the University of Liverpool—Let us know if you like our work by following us on LinkedIn, signing up for our bi-weekly Inside AI in Life Science Newsletter, or subscribing to our podcast on a relevant platform for you.—Other podcast platforms:Google PodcastsSpotifyYouTube—Hosts:Elisa Opriessnig and Benjamin Obexer—Image analysis and AI application training IKOSA platform app.ikosa.ai—Social media:Facebook and Twitter—https://www.kmlvision.com/office@kmlvision.comKML Vision GmbHNikolaiplatz 4, 2nd floorGraz Austria—Music attributions:https://pixabay.com/music/beats-jazzy-abstract-beat-11254/ 

Join us in our second episode as we explore the world of biotechnology with an expert who brings over two decades of experience in the biopharmaceutical industry: Klaus Graumann . Armed with a PhD in Biotechnology, he embarked on an incredible journey that led him to depart from the corridors of Big Pharma in 2018 and transition into the entrepreneurial realm, becoming the Biotech Consultant and CEO at Phoenestra GmbH.In this exclusive interview, Klaus Graumann shares his profound insights, gained through years of industry expertise, and his bold venture in steering Phoenestra towards pioneering platform technologies focused on the development of stem cell-derived products. Join us as we uncover the innovative pathways and visionary strategies fueling the future of biotech through the lens of his expertise and entrepreneurial acumen.Further links to our guest's profiles:PhoenestraKlaus Graumann's LinkedIn Profile---Let us know if you like our work by following us on LinkedIn, signing up for our bi-weekly Inside AI in Life Science Newsletter, or subscribing to our podcast on a relevant platform for you.---Other podcast platforms:Google PodcastsSpotifyYouTube---Hosts:Elisa Opriessnig and Benjamin Obexer---Image analysis and AI application training IKOSA platform app.ikosa.ai---Social media:Facebook and Twitter---https://www.kmlvision.com/office@kmlvision.comKML Vision GmbHNikolaiplatz 4, 2nd floorGraz Austria---Music attributions:https://pixabay.com/music/beats-jazzy-abstract-beat-11254/